which confer vancomycin resistance in enterococci.
which confer vancomycin resistance in enterococci.
39
We previously published a targeted treatment algorithm based on BC-GP results
40
(2). In this study, we evaluate clinical outcomes associated with implementation of the Additionally, if a subject had a second blood culture that was positive for the same 53 organism within 14 days of the first culture, the second culture was excluded.
54
In the pre-intervention period, Gram stain results were documented in the The EMR was used to determine the time to appropriate and acceptable therapy. 
106
Limitations of the study include that it was conducted at a single center with a 107 small sample size and was limited by the number of cases that occurred. Many subjects 108 were excluded due to polymicrobial blood cultures (n=62). Several patients were on 109 appropriate or acceptable therapy before the BC-GP result due to empiric treatment. The 110 study does not control for the stewardship intervention itself; therefore, it is impossible to 111 know if differences observed were a product of the technology, stewardship, or both.
112
In conclusion, minimizing time to targeted antimicrobial therapy may reduce 
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